Haynes and Boone represented Chembio Diagnostics, Inc. in its public offering of 1,783,760 shares of common stock for $6.75 per share. The offering closed on February 12, 2018.
Representative Matters /
Chembio Diagnostics, Inc. Public Offering
Chembio Diagnostics, Inc. Public Offering of Shares of Common Stock
Participating Lawyers

Partner | Co-Chair, Food, Beverage and Restaurant Practice Group
T +1 214.651.5098 Email